Both in Pharmaceuticals
Sionna Therapeutics vs Niagen Bioscience
Over the past year SION returned −82.6% and NAGE returned −70.2%; their daily moves had a correlation of 0.11.
SION −82.6% NAGE −70.2%Growth of $1, one year, split-adjusted
| Metric | SION | NAGE |
|---|---|---|
| Price | $5.15 | $2.95 |
| Market cap | $232.8M | $233.4M |
| Today | +0.59% | −1.01% |
| 1 month | −12.3% | −10.3% |
| 6 months | −86.0% | −31.1% |
| Year to date | −87.5% | −53.6% |
| 1 year | −82.2% | −69.8% |
| Revenue growth (YoY) | — | −4.3% |
| Gross margin | — | 64.8% |
| Net margin | — | 3.2% |
| P/E (TTM) | — | 14.6× |
| Price / sales | — | 1.8× |
| Net cash | $211.0M | $66.7M |
| Dividend yield | — | — |
| Volatility (60d) | 505.3% | 49.6% |
| Short % of float | 25.4% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).